JP2001139481A - Iron absorption-promoting agent - Google Patents
Iron absorption-promoting agentInfo
- Publication number
- JP2001139481A JP2001139481A JP32466699A JP32466699A JP2001139481A JP 2001139481 A JP2001139481 A JP 2001139481A JP 32466699 A JP32466699 A JP 32466699A JP 32466699 A JP32466699 A JP 32466699A JP 2001139481 A JP2001139481 A JP 2001139481A
- Authority
- JP
- Japan
- Prior art keywords
- iron
- absorption
- tea
- tea beverage
- iron absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Tea And Coffee (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】本発明は、鉄剤の吸収を促進し、鉄分不足
を解消することができる鉄吸収促進剤に関する。[0001] The present invention relates to an iron absorption promoter capable of promoting absorption of an iron agent and eliminating iron deficiency.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】我が国
では、女性の鉄分摂取不足が慢性化してきている( 厚生
省「平成8年度国民栄養の現状」)。特に若年女性は、
ダイエットなどの偏食による潜在性鉄欠乏や鉄欠乏症貧
血が危惧されるところである。2. Description of the Related Art In Japan, the shortage of iron intake in women has become chronic (Ministry of Health and Welfare, "Current state of national nutrition in 1996"). Especially young women,
Latent iron deficiency and iron deficiency anemia due to unbalanced diet such as dieting are concerned.
【0003】これら鉄欠乏に起因する疾病のほとんどは
鉄剤の投与により軽快するが、古くから、この鉄剤の吸
収はお茶などのタンニン含有飲料が阻害されると言われ
ており、長年にわたり鉄剤服用患者に対してお茶、コー
ヒーなどのタンニン含有飲料の摂取を禁止する指導がな
されてきた(薬局Vol.39,No.1(1988)
「薬の生体内動態(13)」)。しかし最近では、鉄吸収に
対するお茶等の影響を否定する報告や、鉄剤と茶を併用
しても貧血の回復は十分に見られるとの報告も散見され
るようになり、お茶等のタンニン含有飲料を摂取すると
本当に鉄吸収が阻害されるのかという問題は未だ未解決
である。[0003] Most of the diseases caused by iron deficiency are relieved by administration of iron preparations. However, it has long been said that absorption of the iron preparations is inhibited by tannin-containing beverages such as tea, and patients taking iron preparations have been known for many years. Have been instructed to prohibit the consumption of tannin-containing beverages such as tea and coffee (Pharmacy Vol. 39, No. 1 (1988)).
“Drug pharmacokinetics (13)”). However, recently, there have been reports that deny the effects of tea and the like on iron absorption and reports that the recovery of anemia can be sufficiently observed even when iron and tea are used in combination. The question of whether iron intake actually inhibits iron absorption remains unsolved.
【0004】他方、近年健康嗜好やペットボトル飲料の
普及に伴い、若年層にも急速に緑茶が飲まれはじめてお
り、上述のような若年女性の潜在性鉄欠乏や鉄欠乏症貧
血の危惧からすれば、早急に上記問題点の解決が図られ
るべきである。そこで本発明者らは、若年女性を対象と
して鉄吸収における緑茶の影響を様々な観点から鋭意試
験していく中で、従来開示されていない新たな知見を
得、かかる知見に基づいて本発明をなすに至ったもので
ある。[0004] On the other hand, green tea has begun to be drunk by young people in recent years with the popularization of health and the popularization of plastic bottled drinks, and as described above, the fear of latent iron deficiency and iron deficiency anemia in young women as described above. The above problems should be resolved as soon as possible. Therefore, the present inventors, while working diligently from various viewpoints on the effect of green tea on iron absorption for young women, obtained new findings that have not been previously disclosed, and based on such findings, the present invention It is something that has been done.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明者ら
が、若年女性を対象として鉄吸収における緑茶の影響を
様々な観点から試験した結果、驚いたことに容器詰め茶
飲料と鉄剤とを併用させると鉄剤の吸収が逆に促進され
るという結果を得ることができた。かかる結果に基づ
き、本発明は、容器詰め茶飲料成分を有効成分としてな
る鉄吸収促進剤を開発した。しかしながら、なぜ容器詰
め茶飲料がこのような鉄吸収促進効果を発揮するのかは
未だ不明である。That is, as a result of the present inventors testing the effect of green tea on iron absorption from various viewpoints for young women, it was surprisingly found that a bottled tea beverage was used in combination with an iron preparation. By doing so, it was possible to obtain the result that absorption of the iron agent was promoted on the contrary. Based on these results, the present invention has developed an iron absorption promoter containing a packaged tea beverage ingredient as an active ingredient. However, it is still unclear why packaged tea beverages exhibit such an iron absorption promoting effect.
【0006】ここで、本発明における容器詰め茶飲料成
分とは、容器詰め茶飲料に含有される成分を意味し、か
かる容器詰め茶飲料とは、缶、透明容器、紙製容器等の
容器に詰められた茶飲料若しくはそのような容器詰めの
ための茶飲料を意味する。そしてこれら「容器詰め茶飲
料」は、茶葉を40〜100℃の温水中で約1分〜10
分間抽出した後、金属網、布等により茶殻を除去し、L
−アスコルビン酸を用いてその抽出液のpHを約4.0
〜5.0の酸性域に調整し、次いでこれを室温以下好ま
しくは20℃以下に急冷するなどして濁りやオリの形成
を促進させてこれらを遠心分離その他の手段で除去し、
必要に応じて更に微細濾過した後、抽出液のpHを炭酸
水素ナトリウムやアスコルビン酸ナトリウム等を使用し
て約5.5〜7.0の中性域に調整し、そして加熱殺菌
後容器に充填しレトルト殺菌するか、或いは前記の如く
中性域に調整した後、超高温殺菌処理を行った後容器に
無菌充填するものであるという特徴を有している。Here, the packaged tea beverage component in the present invention means a component contained in the packaged tea beverage, and such a packaged tea beverage refers to a container such as a can, a transparent container, and a paper container. A packed tea beverage or tea beverage for such packaging is meant. And these "container-packed tea drinks" are prepared by brewing tea leaves in warm water at 40 to 100C for about 1 minute to 10 minutes.
After extracting for 5 minutes, remove the tea husk with a metal net, cloth, etc.
The pH of the extract is about 4.0 using ascorbic acid
Adjusted to an acidic range of ~ 5.0, and then rapidly cooled to room temperature or lower, preferably 20 ° C or lower to promote the formation of turbidity or ori and remove them by centrifugation or other means,
After further fine filtration as needed, adjust the pH of the extract to a neutral range of about 5.5 to 7.0 using sodium hydrogen carbonate, sodium ascorbate, etc., and fill in a container after heat sterilization. After retort sterilization, or after adjusting to the neutral region as described above, ultrahigh-temperature sterilization is performed, and then the container is filled aseptically.
【0007】[0007]
【発明の実施の形態】本発明の鉄吸収促進剤は、上述の
ように茶葉を温水抽出した後、酸性域に調整し、急冷す
るなどして濁りやオリの形成を促進させてこれらを除去
し、必要に応じて更に微細濾過を行い、抽出液のpHを
約5.5〜7.0の中性域に調整し、そして加熱殺菌後
容器に充填しレトルト殺菌するか、或いは前記の如く中
性域に調整した後、超高温殺菌処理を行った後容器に無
菌充填した茶飲料、或いは前記の如く中性域に調整した
後殺菌処理を施して得られる茶飲料を、そのまま、或い
は濃縮して、或いは凍結乾燥或いは噴霧乾燥などにより
乾燥させて乾燥粉末として提供することができる。BEST MODE FOR CARRYING OUT THE INVENTION The iron absorption enhancer of the present invention removes tea leaves by extracting tea leaves with hot water as described above, adjusting to an acidic region, and rapidly cooling to promote the formation of turbidity and dust. Then, if necessary, fine filtration is further performed, the pH of the extract is adjusted to a neutral range of about 5.5 to 7.0, and after heat sterilization, filled in a container and sterilized by retort, or as described above. After adjusting to the neutral region, the tea beverage aseptically filled in the container after performing the ultra-high temperature sterilization treatment, or the tea beverage obtained by performing the sterilization treatment after adjusting to the neutral region as described above, as it is, or concentrated Or dried by freeze drying or spray drying to provide a dry powder.
【0008】また、提供の形態としては、医薬品、医薬
部外品、鉄吸収促進効果を示す飲食物などとして様々に
利用することができる。医薬品として調整する場合、液
剤、錠剤、散剤、顆粒、糖衣錠、カプセル、トローチ
剤、シロップ剤など様々な剤型として提供することもで
きる。医薬部外品として調製する場合も、これを缶ドリ
ンク飲料、瓶ドリンク飲料などの飲料形態、或いはタブ
レット、カプセル、トローチ(飴)、顆粒などの形態と
して日常的に容易に摂取することより生体に対して十分
な薬理効果をもたらす医薬部外品として提供することも
できる。[0008] As a form of provision, it can be variously used as pharmaceuticals, quasi-drugs, foods and drinks having an iron absorption promoting effect, and the like. When prepared as a medicament, it can be provided in various dosage forms such as liquids, tablets, powders, granules, dragees, capsules, troches and syrups. When it is prepared as a quasi-drug, it can be taken into the living body by taking it easily in the form of beverages such as canned drinks and bottled drinks, or in the form of tablets, capsules, troches (candy) and granules. It can also be provided as a quasi-drug that provides a sufficient pharmacological effect.
【0009】鉄吸収促進飲食物として提供する場合、例
えば本発明における有効成分と、食品素材(果実やゼリ
ーなども含む)、乳成分、炭酸、賦形剤(造粒剤含
む)、希釈剤、或いは更に甘味剤、フレーバー、小麦
粉、でんぷん、糖、油脂類等の各種タンパク質、糖質原
料やビタミン、ミネラルなどから選ばれた一種或いは二
種以上とを混合し、缶飲料、ボトル飲料、固形食物など
に調製し、スポーツ飲料、果実飲料、乳飲料、乳性飲
料、ゼリー、ゼリー飲料、炭酸飲料など様々な飲食物と
して提供することができる。When provided as a food or drink for promoting iron absorption, for example, the active ingredient of the present invention, a food material (including fruit and jelly), a milk component, carbonic acid, an excipient (including a granulating agent), a diluent, Alternatively, a sweetener, flavor, flour, starch, sugar, fats, and other proteins, carbohydrate raw materials, vitamins, minerals, and the like, or a mixture of two or more selected from minerals, can beverages, bottled beverages, solid foods Etc., and can be provided as various foods and drinks such as sports drinks, fruit drinks, milk drinks, milk drinks, jelly, jelly drinks, carbonated drinks and the like.
【0010】(試験)若年女性を対象として、鉄吸収に
おける緑茶の影響を試験した。(Test) The effect of green tea on iron absorption was tested on young women.
【0011】−対象者− 食事の交絡因子を排除するため、同じ寮に住む寮生を対
象とし、検診の後、18歳から22歳までの健康な女性
50人を試験対象とした。なお、生理期間中の者、喫煙
者及び鉄欠乏性貧血患者などは除いた。-Subjects- To eliminate confounding factors in the diet, the subjects were dormitory students living in the same dormitory. After the medical examination, 50 healthy women aged 18 to 22 were tested. In addition, persons during the period of menstruation, smokers, and patients with iron deficiency anemia were excluded.
【0012】−試験方法− 実験日の2週間前から食事のコントロールを行い(図1
参照)、実験当日は、対象をランダムに下記表1の4群
に分け、図2に示したタイムスケジュールに従い、各対
象群ごとに負荷実験と採血とを行った。採血は、負荷前
(早朝空腹時:0時)と負荷後1時間、3時間、5時
間、7時間後に行った。-Test Method- Two weeks before the experiment day, the diet was controlled (FIG. 1).
On the day of the experiment, subjects were randomly divided into the four groups shown in Table 1 below, and a loading experiment and blood sampling were performed for each subject group according to the time schedule shown in FIG. Blood was collected before loading (early morning fasting: 0:00) and 1, 3, 5 and 7 hours after loading.
【0013】[0013]
【表1】 [Table 1]
【0014】本実験において、「鉄剤」としてはフェロ
ミア(成分:クエン酸第一鉄ナトリウム、エーザイ社
製)を用い、1回の負荷につき2錠(鉄として100m
g)を摂取させた。In this experiment, ferromia (component: sodium ferrous citrate, manufactured by Eisai Co., Ltd.) was used as the "iron agent", and two tablets (100 m as iron) per load were used.
g).
【0015】また、「緑茶」としては、茶葉を70℃の
温水中で約6分間抽出した後、布により茶殻を除去し、
L−アスコルビン酸を用いてその抽出液のpHを約4.
5の酸性域に調整し、次いでこれを20℃以下に急冷し
て発生した濁りやオリを濾過除去した後、抽出液のpH
を炭酸水素ナトリウム及びアスコルビン酸ナトリウムを
使用して約6の中性域に調整し、加熱殺菌後、缶に充填
し巻き締めし、レトルト殺菌した缶入り茶飲料を使用
し、1回の負荷につき340gを常温にて飲用させた。As "green tea", after extracting tea leaves in hot water at 70 ° C. for about 6 minutes, the tea husk is removed with a cloth,
The pH of the extract was adjusted to about 4.
5 and then rapidly cooled to 20 ° C or less to remove the turbidity and scum generated by filtration.
Is adjusted to about 6 neutral range using sodium bicarbonate and sodium ascorbate, heat sterilized, filled into cans, tightly wound, and used a canned tea beverage sterilized by retort. 340 g were drunk at room temperature.
【0016】上記茶飲料における各成分含有量乃至濃度
は次の通りであった。 鉄・・・・・・ 0.02mg/100g カルシウム・・ 0.2 mg/100g カリウム・・・10.9 mg/100g マグネシウム・ 0.6 mg/100g マンガン・・・ 0.14mg/100g タンニン・・・ 613μg/ml GC ・・・ 139ppm EGC ・・・ 72ppm (+)C ・・・ 49ppm Caf ・・・ 132ppm EC ・・・ 35ppm EGCg・・・ 102ppm GCg ・・・ 115ppm ECg ・・・ 38ppm Cg ・・・ 33ppm −アミノ酸− Asp ・・・10.0 μg/ml Glu ・・・11.3 μg/ml Asn ・・・ 1.3 μg/ml Ser ・・・ 2.6 μg/ml Gln ・・・ 0.9 μg/ml Arg ・・・ 2.5 μg/ml Ala ・・・ 1.3 μg/ml The ・・・31.7 μg/ml (テアニン)The content or concentration of each component in the above tea beverage was as follows. Iron: 0.02 mg / 100 g Calcium: 0.2 mg / 100 g Potassium: 10.9 mg / 100 g Magnesium: 0.6 mg / 100 g Manganese: 0.14 mg / 100 g Tannin 613 μg / ml GC 139 ppm EGC 72 ppm (+) C 49 ppm Caf 132 ppm EC 35 ppm EGCg 102 ppm GCg 115 ppm ECg 38 ppm Cg 33 ppm-amino acid-Asp: 10.0 μg / ml Glu: 11.3 μg / ml Asn: 1.3 μg / ml Ser: 2.6 μg / ml Gln: 0.9 μg / ml Arg 2.5 μg / ml Ala 1.3 μg / ml Th ··· 31.7 μg / ml (theanine)
【0017】(結果)上記試験の結果を図3〜図6に示
す。血清鉄濃度については、3群(鉄剤+水)及び4群
(鉄剤+緑茶)は、1群(水)及び2群(緑茶)より有
意に高値を示した。総鉄結合能(TIBC)及び血清フ
ェリチン(腸粘膜の鉄吸収に働き、肝臓、脾臓その他の
組織における鉄の貯蔵タンパクとして働く)に変化はな
かったが、不飽和鉄結合能(UIBC)については、3
群(鉄剤+水)及び4群(鉄剤+緑茶)が、1群(水)
及び2群(緑茶)より有意に低値を示した。すなわち、
吸収した鉄がトランスフェリン(2原子の鉄と結合して
いるグロブリンで、血液中で鉄を移送するのに働く。グ
ロブリンとは、水にほとんど不溶の球状の単純タンパク
質)に結合したことが示された。(Results) The results of the above test are shown in FIGS. Regarding the serum iron concentration, the groups 3 (iron preparation + water) and 4 (iron preparation + green tea) showed significantly higher values than the groups 1 (water) and 2 (green tea). There was no change in total iron binding capacity (TIBC) and serum ferritin (acting on iron absorption in the intestinal mucosa and acting as an iron storage protein in liver, spleen and other tissues), but unsaturated iron binding capacity (UIBC). , 3
Group (iron preparation + water) and 4 groups (iron preparation + green tea), 1 group (water)
And 2 groups (green tea) showed significantly lower values. That is,
The absorbed iron is shown to be bound to transferrin (a globulin that binds to two atoms of iron and acts to transport iron in the blood; globulin is a globular simple protein that is almost insoluble in water). Was.
【0018】人は、鉄欠乏になると、貯蔵鉄、血清鉄、
ヘモグロビン、組織鉄の順に低下することが分かってい
る。本試験では、いずれの群も貯蔵鉄を反映する血清フ
ェリチンに影響は見られなかったものの、血清鉄につい
ては、鉄剤+水を摂取することにより上昇し、これより
も更に、鉄剤+緑茶を摂取すると上昇する結果が得られ
た。つまり、緑茶の摂取によって鉄剤の吸収を促進し得
ることが判明した。なお、緑茶を摂取した場合、Naや
Kなどの鉄以外の血清ミネラル成分には影響はなかった
ことも確認されている。[0018] When iron deficiency occurs, humans can store iron, serum iron,
It is known that hemoglobin and tissue iron decrease in this order. In this test, there was no effect on serum ferritin reflecting stored iron in any group, but serum iron was increased by ingestion of iron + water, and further ingestion of iron + green tea The result was ascending. That is, it was found that the intake of the green tea could promote the absorption of the iron agent. In addition, it was also confirmed that the consumption of green tea had no effect on serum mineral components other than iron, such as Na and K.
【0019】[0019]
【発明の効果】本発明の鉄吸収促進剤は、鉄剤摂取と同
時、或いは摂取前後に摂取することにより、鉄吸収を促
進することができ、鉄欠乏に起因する様々な疾病の治療
及び予防、更には若年女性に見られる潜在性鉄欠乏の改
善に効果を発揮する。また、茶飲料は古くから日常的に
飲用されており、その安全性は確かであるから継続的な
摂取も有効であり、その効果も期待できるところであ
る。The iron absorption enhancer of the present invention can promote iron absorption when taken at the same time as or before and after ingestion of an iron agent, and can treat and prevent various diseases caused by iron deficiency. It is also effective in reducing latent iron deficiency found in young women. In addition, tea beverages have been used on a daily basis since ancient times, and since their safety is certain, continuous ingestion is effective, and the effect can be expected.
【図1】人試験における食事コントロールのスケジュー
ルを示した図である。FIG. 1 is a diagram showing a schedule of meal control in a human test.
【図2】人試験当日のスケジュールを示した図である。FIG. 2 is a diagram showing a schedule on the day of a human test.
【図3】各試験対象群における血清鉄濃度(μg/d
l)の経時変化を示したグラフである。FIG. 3 shows serum iron concentration (μg / d) in each test group.
1 is a graph showing a change over time of l).
【図4】各試験対象群におけるTIBC(μg/dl)
の経時変化を示したグラフである。FIG. 4 TIBC (μg / dl) in each test group
5 is a graph showing a change with time of the graph.
【図5】各試験対象群におけるフェリチン濃度(ng/
dl)の経時変化を示したグラフである。FIG. 5: Ferritin concentration (ng / ng) in each test group
It is the graph which showed the time-dependent change of dl).
【図6】各試験対象群におけるUIBC(μg/dl)
の経時変化を示したグラフである。FIG. 6: UIBC (μg / dl) in each test group
5 is a graph showing a change with time of the graph.
フロントページの続き (72)発明者 小切間 美保 大阪市東成区大今里西3丁目10−1 ビル シャナ201号室 (72)発明者 西野 幸典 長岡京市河陽が丘2丁目8−11 (72)発明者 西村 公雄 大津市尾花川19−1 コーポアイリス205 号室 Fターム(参考) 4B027 FB13 FC06 FE08 FK03 FP74 FP85 FR01 4C088 AB45 AC05 BA09 CA05 NA11 ZA51 Continued on the front page (72) Inventor Miho Korikima 3-10-1 Oimasato Nishi, Higashinari-ku, Osaka Building Shana 201 Room (72) Inventor Yukinori Nishino 2-8-11 Kawayogaoka, Nagaokakyo-shi (72) Invention Person Kimio Nishimura 19-1 Obanakawa, Otsu City Corp. Iris Room 205 F-term (reference) 4B027 FB13 FC06 FE08 FK03 FP74 FP85 FR01 4C088 AB45 AC05 BA09 CA05 NA11 ZA51
Claims (2)
る鉄吸収促進剤。1. An iron absorption promoter comprising a packaged tea beverage ingredient as an active ingredient.
100℃の温水中で約1分〜10分間抽出した後、茶殻
を除去し、L−アスコルビン酸を用いてその抽出液のp
Hを約4.0〜5.0の酸性域に調整し、次いでこれを
室温以下好ましくは20℃以下に急冷するなどして濁り
やオリの形成を促進させてこれらを濾過する等の方法に
よって除去した後、抽出液のpHを約5.5〜7.0の
中性域に調整し、殺菌処理して得られる茶飲料である請
求項1に記載の鉄吸収促進剤。2. The container-filled tea beverage according to claim 1, wherein the tea leaves are 40 to
After extraction in warm water at 100 ° C. for about 1 minute to 10 minutes, the tea husk is removed, and the extract is extracted using L-ascorbic acid.
H is adjusted to an acidic range of about 4.0 to 5.0, and then quenched to room temperature or lower, preferably 20 ° C. or lower to promote formation of turbidity or dust and to filter them. The iron absorption enhancer according to claim 1, which is a tea beverage obtained by removing the extract, adjusting the pH of the extract to a neutral range of about 5.5 to 7.0, and sterilizing the tea drink.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32466699A JP2001139481A (en) | 1999-11-15 | 1999-11-15 | Iron absorption-promoting agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32466699A JP2001139481A (en) | 1999-11-15 | 1999-11-15 | Iron absorption-promoting agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001139481A true JP2001139481A (en) | 2001-05-22 |
Family
ID=18168384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32466699A Pending JP2001139481A (en) | 1999-11-15 | 1999-11-15 | Iron absorption-promoting agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001139481A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007535954A (en) * | 2004-05-04 | 2007-12-13 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Tea extract |
EP2420243A1 (en) | 2010-08-18 | 2012-02-22 | Inovativo Biomedicinas Tehnologiju Instituts, SIA | Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming |
JP2019147772A (en) * | 2018-02-28 | 2019-09-05 | サッポロホールディングス株式会社 | Hepcidin expression inhibitor, and food and drink for improvement and/or prevention of iron-deficiency anemia |
-
1999
- 1999-11-15 JP JP32466699A patent/JP2001139481A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007535954A (en) * | 2004-05-04 | 2007-12-13 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Tea extract |
EP2420243A1 (en) | 2010-08-18 | 2012-02-22 | Inovativo Biomedicinas Tehnologiju Instituts, SIA | Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming |
JP2019147772A (en) * | 2018-02-28 | 2019-09-05 | サッポロホールディングス株式会社 | Hepcidin expression inhibitor, and food and drink for improvement and/or prevention of iron-deficiency anemia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4903436B2 (en) | Lipase activity inhibitor, tea extract containing high-molecular polyphenol fraction, and method for producing the same | |
KR100841834B1 (en) | Physiologically functional drinks and compositions | |
US20120052138A1 (en) | Composition comprising green tea extract | |
CA2623418C (en) | Use of a polyphenol extract of grape for lowering blood pressure in a subject suffering from metabolic syndrome or pre-hypertension | |
Butacnum et al. | Black tea consumption improves postprandial glycemic control in normal and pre-diabetic subjects: A randomized, double-blind, placebo-controlled crossover study | |
JPH0789852A (en) | Water-soluble powder containing calcium in high concentration and its production | |
JP2006193502A (en) | Adiponectin regulating agent and food, drink, food additive and medicine containing the same | |
JP2009298769A (en) | Fat accumulation-suppressing composition | |
JP5414995B2 (en) | Acidic urine-improving food and drink and pharmaceutical composition for oral administration comprising fucoidan as an active ingredient | |
JP4406780B2 (en) | Method for producing anti-influenza virus agent and other drugs using active ingredient of birch moth, and method for producing health food and drink product | |
JP4494033B2 (en) | Serum cholesterol lowering agent, food and drink, and method for producing the same | |
JPH05268920A (en) | Health food and health drink | |
JP2001048797A (en) | Oral administration preparation for treating dementia | |
JP4317781B2 (en) | Beverage containing catechins in containers | |
JP2001139481A (en) | Iron absorption-promoting agent | |
TWI627962B (en) | Composition for improving blood glucose metabolism | |
JP4673071B2 (en) | Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof | |
CN109430478A (en) | A kind of zinc selenium composite instant tea and preparation method thereof | |
JP4494373B2 (en) | Method for producing catechin-containing food and drink | |
WO2006064761A1 (en) | Adiponectin regultor and foods, drinks, food aditives and drugs containing the same | |
KR100584153B1 (en) | Manufacture method, Various uses and Extracts for The Development of Anticonspitation Functional food materials from Oriental Herbal Medicines | |
JP4435882B2 (en) | Alcohol absorption inhibiting composition | |
JPH11269082A (en) | Food having human blood serum cholesterol depressing action and preventive or treating agent for human hypercholesterolemia or human arterial sclerosis | |
JPH10127254A (en) | Health food for constipation | |
JP2006328025A (en) | Nitric oxide regulator, food and beverage containing the same, food additive, medicine and cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050427 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090210 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090428 |